0,893  0,002  Sensitization
0,874  0,004  Antihypercholesterolemic
0,839  0,012  Apoptosis agonist
0,801  0,011  Caspase 9 stimulant
0,790  0,017  Antiinflammatory
0,691  0,009  Cholesterol antagonist
0,677  0,021  Antineoplastic (lung cancer)
0,678  0,023  Transcription factor NF kappa B inhibitor
0,624  0,005  Antineoplastic (endocrine cancer)
0,630  0,020  Antileukemic
0,600  0,011  Antineoplastic (pancreatic cancer)
0,592  0,012  Hepatic disorders treatment
0,568  0,006  Antihypoxic
0,572  0,011  Nitric oxide antagonist
0,591  0,036  Antineoplastic (breast cancer)
0,551  0,018  Antineoplastic (melanoma)
0,518  0,006  Anesthetic
0,524  0,026  Antipruritic, allergic
0,501  0,009  UGT1A4 substrate
0,500  0,019  Chemopreventive
0,488  0,014  ICAM1 expression inhibitor
0,473  0,002  Ornithine decarboxylase inhibitor
0,464  0,008  Abortion inducer
0,487  0,037  Immunosuppressant
0,467  0,018  Antipyretic
0,457  0,009  Hair growth stimulant
0,452  0,004  Antihyperlipoproteinemic
0,470  0,025  Lipoprotein disorders treatment
0,451  0,008  Interferon gamma antagonist
0,449  0,007  Antiacne
0,474  0,034  Vasodilator, peripheral
0,460  0,026  NOS3 expression inhibitor
0,442  0,008  Prostate disorders treatment
0,436  0,005  Antiviral (Influenza A)
0,480  0,052  TNF expression inhibitor
0,442  0,018  Hypolipemic
0,462  0,039  Prostate cancer treatment
0,429  0,010  Prostatic (benign) hyperplasia treatment
0,447  0,030  Antipsoriatic
0,449  0,035  Antineoplastic (ovarian cancer)
0,422  0,008  Antiviral (Influenza)
0,418  0,014  Anesthetic general
0,413  0,012  Hepatoprotectant
0,405  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,433  0,034  Caspase 3 stimulant
0,460  0,063  Cyclophilin D inhibitor
0,460  0,063  Antidiabetic
0,404  0,008  Protein-tyrosine phosphatase inhibitor
0,404  0,016  Sodium/bile acid cotransporter inhibitor
0,424  0,040  Respiratory analeptic
0,440  0,058  15-Lipoxygenase inhibitor
0,402  0,023  Antineoplastic (liver cancer)
0,388  0,015  Contraceptive
0,407  0,036  Cardioprotectant
0,383  0,013  UGT2B7 substrate
0,368  0,004  ABCA1 expression enhancer
0,399  0,036  Antineoplastic (glioma)
0,386  0,023  Antihypertriglyceridemic
0,412  0,060  Atherosclerosis treatment
0,366  0,014  Antipruritic, non-allergic
0,388  0,038  Antineoplastic (cervical cancer)
0,387  0,042  Apoptosis antagonist
0,358  0,013  Lipocortins synthesis antagonist
0,397  0,054  Antineoplastic (colorectal cancer)
0,365  0,029  Vascular (periferal) disease treatment
0,369  0,033  Hypoglycemic
0,374  0,039  Chemoprotective
0,342  0,008  Cholesterol synthesis inhibitor
0,369  0,038  UGT2B4 substrate
0,375  0,045  CYP2C19 substrate
0,383  0,054  Bone diseases treatment
0,368  0,040  Cytotoxic
0,349  0,023  Muscle relaxant
0,349  0,024  Antiparkinsonian, rigidity relieving
0,378  0,054  Antineoplastic (colon cancer)
0,364  0,041  Calcium channel activator
0,362  0,043  Antioxidant
0,365  0,051  AR expression inhibitor
0,327  0,018  Gastrin inhibitor
0,312  0,003  5-Alpha-reductase inhibitor
0,324  0,019  Diuretic
0,313  0,011  Insulin secretagoues
0,346  0,052  Analeptic
0,341  0,064  Antifungal
0,291  0,018  Protein kinase stimulant
0,328  0,056  Antiosteoporotic
0,322  0,050  NOS2 expression inhibitor
0,303  0,031  UGT1A1 substrate
0,347  0,079  CYP3A4 substrate
0,300  0,034  Platelet adhesion inhibitor
0,269  0,004  Actinic keratosis treatment
0,359  0,096  Histamine release inhibitor
0,306  0,045  Antineoplastic (glioblastoma multiforme)
0,278  0,025  Neurotrophic factor enhancer
0,271  0,019  Interleukin 6 antagonist
0,321  0,073  Immunostimulant
0,292  0,045  Antiparasitic
0,253  0,009  Antiinfertility, female
0,296  0,053  Proliferative diseases treatment
0,279  0,037  Antihelmintic
0,267  0,028  Antiviral (Herpes)
0,241  0,008  HDL-cholesterol increasing
0,301  0,070  5 Hydroxytryptamine release stimulant
0,240  0,009  Contraceptive female
0,286  0,056  Cardiovascular analeptic
0,234  0,005  Potassium channel large-conductance Ca-activated activator
0,291  0,064  Teratogen
0,235  0,014  Farnesoid X receptor antagonist
0,231  0,012  Choleretic
0,239  0,023  UGT2B9 substrate
0,258  0,047  UDP-glucuronosyltransferase substrate
0,273  0,063  Antiprotozoal (Leishmania)
0,245  0,037  Insulin sensitizer
0,272  0,066  Embryotoxic
0,211  0,009  TRPA1 agonist
0,224  0,026  Anesthetic local
0,200  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,254  0,058  Antiulcerative
0,240  0,047  Non-steroidal antiinflammatory agent
0,299  0,107  CYP2C9 substrate
0,197  0,009  Keratolytic
0,224  0,039  Acaricide
0,284  0,101  Vasodilator, coronary
0,195  0,015  Potassium channel (Ca-activated) activator
0,280  0,103  Antithrombotic
0,201  0,028  Antiviral (Hepatitis B)
0,249  0,075  Tumour necrosis factor alpha release inhibitor
0,245  0,072  Vasodilator
0,237  0,068  UGT1A6 substrate
0,176  0,008  Anabolic
0,267  0,100  Interleukin 2 agonist
0,212  0,045  UGT1A3 substrate
0,237  0,073  Cardiodepressant
0,180  0,016  Androgen antagonist
0,198  0,035  Arachidonic acid antagonist
0,234  0,077  Angiogenesis stimulant
0,182  0,027  Cyclooxygenase 3 inhibitor
0,198  0,045  Phospholipase C inhibitor
0,215  0,064  Wound healing agent
0,194  0,043  Skeletal muscle relaxant
0,237  0,089  Interleukin agonist
0,159  0,011  CDC25A inhibitor
0,176  0,029  Adenylate cyclase stimulant
0,146  0,004  Liver X receptor alpha agonist
0,251  0,117  Antineoplastic (brain cancer)
0,203  0,071  Sedative
0,232  0,100  Spasmolytic
0,139  0,010  Bile acid receptor antagonist
0,146  0,017  Transcription factor NF kappa B stimulant
0,238  0,111  Hypoxia-inducible factor 1 alpha inhibitor
0,184  0,059  Antihelmintic (Nematodes)
0,155  0,031  Alcohol dehydrogenase substrate
0,232  0,110  Antineoplastic (multiple myeloma)
0,133  0,011  Hyperparathyroidism treatment
0,127  0,009  Anticholelithogenic
0,227  0,109  Antidiabetic (type 2)
0,223  0,108  Transcription factor STAT3 inhibitor
0,171  0,056  UGT2B15 substrate
0,128  0,012  Na+ K+ transporting ATPase inhibitor
0,157  0,045  DNA polymerase I inhibitor
0,120  0,009  Acetyl-CoA transferase inhibitor
0,212  0,101  Antineoplastic (renal cancer)
0,124  0,013  Estrogen agonist
0,149  0,042  Growth stimulant
0,168  0,061  Melanin inhibitor
0,110  0,005  Heme oxygenase stimulant
0,108  0,003  Cholesterol ester transfer protein antagonist
0,214  0,111  UGT1A9 substrate
0,152  0,049  Pregnane X receptor agonist
0,172  0,071  Toxic, respiratory center
0,211  0,110  Antineoplastic (sarcoma)
0,163  0,063  Phospholipase A2 inhibitor
0,107  0,008  Aldosterone antagonist
0,125  0,027  Paget's disease treatment
0,251  0,154  Antineoplastic (non-Hodgkin's lymphoma)
0,120  0,022  Glutamate release inhibitor
0,178  0,081  P-glycoprotein inhibitor
0,107  0,011  Transcription factor AP-1 inhibitor
0,100  0,005  Retinoid X receptor agonist
0,173  0,079  Antirickettsial
0,125  0,034  Antiviral (SARS coronavirus)
0,125  0,034  Antiviral (Coronavirus)
0,196  0,109  Antineoplastic (non-small cell lung cancer)
0,172  0,084  Carcinogenic
0,114  0,027  Inducible nitric-oxide synthase inhibitor
0,090  0,004  Farnesoid X receptor agonist
0,100  0,016  CDC25B inhibitor
0,178  0,097  VEGF expression inhibitor
0,085  0,007  Retinoid X alpha receptor agonist
0,127  0,050  Endometrios treatment
0,114  0,037  Lanosterol 14 alpha demethylase inhibitor
0,128  0,053  Microtubule formation inhibitor
0,147  0,072  Antidiabetic (type 1)
0,251  0,176  Antibacterial
0,130  0,055  Skin irritative effect
0,134  0,060  Vanilloid 1 agonist
0,087  0,014  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,079  0,006  5-Alpha-reductase 2 inhibitor
0,082  0,010  Liver X receptor agonist
0,134  0,064  Retinoprotector
0,178  0,110  Antineoplastic enhancer
0,118  0,051  AMP-activated protein kinase stimulant
0,121  0,054  Estrogen antagonist
0,186  0,121  Myocardial infarction treatment
0,091  0,027  Glycine receptor agonist
0,070  0,006  5-Alpha-reductase 1 inhibitor
0,159  0,098  LDLR expression enhancer
0,123  0,062  Antitussive
0,070  0,009  RNA-directed RNA polymerase stimulant
0,075  0,014  Acetyl-CoA transferase 2 inhibitor
0,130  0,070  Antihemorrhagic
0,130  0,071  CC chemokine 6 receptor antagonist
0,066  0,008  Parathyroid hormone antagonist
0,232  0,174  Antiobesity
0,103  0,046  Antiviral (Rhinovirus)
0,061  0,005  Retinoid X gamma receptor agonist
0,107  0,051  Estrogen receptor beta antagonist
0,074  0,018  Lipocortins synthesis agonist
0,072  0,018  Diacylglycerol O-acyltransferase inhibitor
0,215  0,161  Antineoplastic (osteosarcoma)
0,061  0,008  Alpha 1L adrenoreceptor agonist
0,061  0,009  Retinoic acid alpha receptor agonist
0,056  0,005  Retinoic acid receptor agonist
0,132  0,082  Lipid peroxidase inhibitor
0,058  0,007  Retinoid X receptor antagonist
0,076  0,026  Androgen agonist
0,074  0,027  Hypercalcemia treatment
0,074  0,028  Nitric oxide donor
0,071  0,026  Postmenopausal disorders treatment
0,149  0,104  ATPase inhibitor
0,054  0,009  Liver X receptor beta agonist
0,051  0,006  Retinoid X alpha receptor antagonist
0,124  0,080  Liver cirrhosis treatment
0,055  0,012  Acetyl-CoA transferase 1 inhibitor
0,233  0,191  CYP2C19 inhibitor
0,105  0,063  Expectorant
0,142  0,101  Liver fibrosis treatment
0,123  0,082  Skin whitener
0,066  0,026  Postcoital contraceptive
0,057  0,020  Cholesterol esterase inhibitor
0,041  0,004  Retinoid X gamma receptor antagonist
0,042  0,008  Liver X receptor alpha antagonist
0,059  0,024  Anesthetic inhalation
0,087  0,052  3C-Like protease (SARS coronavirus) inhibitor
0,212  0,178  FMO1 substrate
0,038  0,005  Retinoic acid alpha receptor antagonist
0,044  0,012  Liver X receptor antagonist
0,046  0,014  Glucose-6-phosphate dehydrogenase inhibitor
0,144  0,113  UGT2B10 substrate
0,035  0,005  Retinoic acid gamma receptor agonist
0,035  0,005  Retinoic acid receptor antagonist
0,144  0,114  Diabetic nephropathy treatment
0,036  0,007  Retinoid X beta receptor agonist
0,148  0,118  Antiviral (Hepatitis)
0,032  0,004  Retinoid X beta receptor antagonist
0,031  0,005  Retinoic acid beta receptor agonist
0,120  0,094  Neurotrophic factor
0,080  0,054  Chymotrypsin inhibitor
0,038  0,013  Liver X receptor beta antagonist
0,095  0,070  Sulfotransferase substrate
0,042  0,018  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,031  0,007  Vitamin D receptor antagonist
0,127  0,104  Antidiarrheal
0,038  0,018  HMG CoA reductase inhibitor
0,085  0,066  Contraceptive male
0,060  0,041  Aromatase inhibitor
0,235  0,222  Calcium channel L-type activator
0,067  0,056  Calcium channel L-type blocker
0,034  0,023  Estrogen receptor beta agonist
0,019  0,008  Vitamin D receptor agonist
0,015  0,005  Retinoic acid beta receptor antagonist
0,015  0,005  Retinoic acid receptor gamma antagonist
0,112  0,103  Antiparkinsonian, tremor relieving
0,153  0,144  Antialcoholic
0,072  0,064  Estrogen receptor alpha antagonist
0,037  0,030  GABA uptake inhibitor
0,091  0,085  UGT2B1 substrate
0,043  0,037  Microtubule stabilization
0,021  0,015  Corticosteroid-like
0,040  0,036  Geranyltranstransferase inhibitor
0,087  0,083  UGT2B11 substrate
0,108  0,104  Cocaine dependence treatment
0,099  0,095  Autism spectrum disorders treatment
0,030  0,027  Estrogen receptor alpha agonist
0,068  0,065  SULT1A2 substrate
0,176  0,174  Transcription factor STAT inhibitor
0,019  0,018  Estrone sulfatase inhibitor
0,080  0,079  Tocolytic

